Acne Medication Market Expected to Reach $10,929 Million by 2025 | CAGR 3.9% - Allied Market Research
PORTLAND, Oregon, July 27, 2018 /PRNewswire/ --
According to a new report published by Allied Market Research, titled, "Acne Medication Market [https://www.alliedmarketresearch.com/acne-medication-market ] by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025," the global acne medication market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025, registering a CAGR of 3.9% from 2018 to 2025.
(Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg )
Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin. It is characterized by the presence of considerable number of pimples, whiteheads, blackheads, oily skin, and probable scarring. It generally affects the skin with comparatively high number of sweat glands at upper part of chest, back, and face. Acne medications are drugs that are indicated for the treatment of acne. These include several prescription and over-the-counter medicines such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives, and others.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4356
The factors that drive the growth of the acne medication market include increase in prevalence of acne vulgaris across the world, unhealthy urban lifestyle, surge in pollution, and rise in focus on skin care products. However, side effects associated with acne medications and reforms, and presence of alternative treatment options such as laser therapies, impede the market growth. Conversely, the development of newer products with lesser side effects and presence of untapped market in the emerging economies are expected to provide lucrative growth opportunities for the market.
The retinoids segment accounted for the largest share in 2017, owing to high usage in treatment of acne and lesser side effects as compared to other therapeutics. However, the salicylic acid segment is expected to grow at the high CAGR from 2018 to 2025.
The inflammatory acne segment is the largest acne type segment in the global acne medication market in 2017 and is expected to maintain its lead in the forecast period. On the other hand, non-inflammatory acne segment is anticipated to record the highest CAGR from 2018-2025.
By type, the prescription medicine segment dominated the global acne treatment market in terms of revenue in 2017 and the trend is projected to continue throughout the forecast period.
The utilization rate of topical medications for acne treatment is high owing to high availability of these products with high success rate and lesser side effects. However, the oral medication segment is expected to grow at a CAGR of 3.6% during the forecast period.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4356
Key findings of the study
- The antibiotics segment accounted for nearly one-fourth share of the global acne
medication market in 2017.
- The over-the-counter medicine segment is expected to grow at a CAGR of 2.9% from 2018
to 2025.
- The non-inflammatory acne segment accounted for around two-fifths share of the global
market in 2017.
- Europe accounted for around one-fourth share of the global market in 2017.
- LAMEA is expected to provide lucrative market growth opportunities and grows with the
CAGR of 4.5% from 2018 to 2025.
North America was the leading revenue contributor to the global acne medication market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the early approval of acne medication products and high adoption of prescription medicines in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 5.6% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward safe acne medications products.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Similar Report:
Dermatological Drugs Market - Global Opportunities and Industry Forecasts, 2017-2023 [https://www.alliedmarketresearch.com/dermatological-drugs-market ]
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1 855 550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Photo:
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
SOURCE Allied Market Research
